GMSH

Hep B and C

Learning from Saskatchewan’s HIV emergency

published: March, 22, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , Hep B and C, Current Affairs, Treatment Guidelines -including when to start, General Health, Mental Health, Health, CATIE - HIV and Hep C Info Resource, Treatment, Media

"...as a nurse, and as a human, I remain disappointed at what I perceive to be the lack of an adequate and equitable HIV response in Saskatchewan." From CATIE Blog, Susanne Nicolay shares the benefit of her 24-plus years' experience there.

Learning from Saskatchewan’s HIV emergency

Saskatchewan has led the country in the rate of new HIV infections and the proportion of people living with HIV since 2009. The HIV epidemic in this province is unique from other jurisdictions in Canada in that more than three-quarters of our new infections occur in people who use injection drugs (the Canadian average is less than 14%). The roots of public health challenges such as HIV and hepatitis C, however, go much deeper than addiction and substance abuse. They started long ago, and they

Grants awarded to 13 Canadian initiatives to help advance the goal of eliminating chronic Hepatitis C infection in high-risk populations

published: March, 22, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, Current Affairs, Health, Revolving Door, Guest Authors, Media

Gilead Canada supports community leaders with local Hepatitis C micro-elimination efforts.

Grants awarded to 13 Canadian initiatives to help advance the goal of eliminating chronic Hepatitis C infection in high-risk populations

Mississauga, ON, March 14, 2018 – In support of Canada’s commitment to the World Health Organization’s (WHO) goal of eliminating chronic hepatitis C infection by 2030, Gilead Sciences Canada, Inc. (Gilead Canada) today announced a series of grants to support screening and linkage to care projects across Canada. These initiatives will focus on hepatitis C screening within high-risk patient populations and linking diagnosed patients to care. In total, 13 Hepatitis C Micro-Elimination Gran

Ontario expands patient access to chronic Hepatitis C therapies on public drug plan.

published: March, 06, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, Current Affairs, Health, Revolving Door, Guest Authors, Media

Good news for those infected or co-infected with Hepatitis C in Ontario

Ontario expands patient access to chronic Hepatitis C therapies on public drug plan.

- Gilead applauds Ontario’s Ministry of Health for expanding access to curative hepatitis C therapies to all diagnosed patients, regardless of severity of illness - Ontario’s expanded access includes EPCLUSA®, a 12 week treatment for patients with chronic hepatitis C across all six genotypes - Gilead’s new product, VOSEVI™ is now available under the Ontario Drug Benefit Program - The removal of the fibrosis level criterion for access furthers Canada’s commitment to the World Heal

Researchers study the impact of co-infection with hepatitis viruses on pregnant women with HIV

published: March, 01, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Hep B and C, CATIE, Women, Research, CATIE - HIV and Hep C Info Resource, Media, Population Specific

From CATIE, Sean R. Hosein reports on a study designed to find out more about the impact of these viruses on pregnancy and birth outcomes in co-infected women.

Researchers study the impact of co-infection with hepatitis viruses on pregnant women with HIV

- Hepatitis C co-infection increases risk of pregnancy complications for women with HIV - Women co-infected with hepatitis C had higher HIV viral loads when giving birth - Researchers suggest screening women with HIV for hepatitis C before pregnancy Due to shared routes of infection, co-infection with hepatitis-causing viruses, particularly hepatitis B-virus (HBV) and/or hepatitis C virus (HCV), is relatively common among some people with HIV. To find out more about the impact of these viru

Add your voice and endorse our call to eliminate hepatitis C in Canada at ctac.ca/EliminateHepC

published: February, 14, 2018 Categories // Social Media, Community Events, Hep B and C, Events, Health, Revolving Door, Guest Authors, Media

Add your voice and endorse our call to eliminate hepatitis C in Canada at ctac.ca/EliminateHepC

Add your voice and endorse our call to Eliminate hepatitis C in Canada at ctac.ca/EliminateHepC Did you know that an estimated 220,000 – 245,000 Canadians are infected with hepatitis C and that around 44% of those individuals are unaware of their status? Hepatitis C is curable, and although Canada has signed up to the World Health Organisation’s target to eliminate viral hepatitis as a public health threat by 2030, we aren't on course to achieve it. That's why CTAC needs your help! Vis

Canadian study links food insecurity to detectable viral loads and decreased CD4+ cells

published: December, 12, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , Hep B and C, Food, Nutrition and Recipes, Treatment Guidelines -including when to start, Research, Health, CATIE - HIV and Hep C Info Resource, Treatment, Living with HIV, Media

Researchers propose “broad multisector interventions that address income, housing affordability, substance use and mental health issues” to address the high degree of food insecurity in their study. From CATIE, Sean R. Hosein reports.

Canadian study links food insecurity to detectable viral loads and decreased CD4+ cells

- Canadian study of people with HIV and hepatitis C co-infection finds that limited access to food is associated with higher levels of HIV in the blood and 10% fewer CD4+ immune cells. - Ontario research reports 70% of HIV-positive participants had experienced food insecurity over the past year, six times greater than HIV-negative people. - Researchers say addressing underlying food insecurity could improve treatment adherence and health outcomes of people living with HIV. Researchers who e

The news on the Canadian criminalization front explained – part one

published: December, 08, 2017 Written by // Bob Leahy - Publisher Categories // African, Caribbean and Black, Activism, Social Media, Gay Men, Hep B and C, Current Affairs, Women, Legal, Media, Bob Leahy - Publisher

Bob Leahy says the news on World AIDS Day that the approach to criminalizing HIV non-disclosure in Canada has changed has left some confused. Here is an easy to follow laymens’ guide to what went down.

The news on the Canadian criminalization front explained – part one

World AIDS Day 2017 saw a dizzying array of announcements. Two in particular contained news of particular importance to people living with HIV. They were about the criminalization of HIV non-disclosure, a complicated topic that generated more commentary and some controversy. The purpose of this article is to explain what the news meant for people living with HIV. Part two will deal with what people are saying about it – and our opinion too. Background: It’s important for people living wit

Police accused of exaggerating risks of HIV to introduce spit guards

published: November, 23, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, Current Affairs, International , Legal, Revolving Door, Media, Guest Authors

Force plans to issue guards to officers from January, saying people infected with blood-borne viruses use spitting as a weapon. From The Guardian, Damien Gayle reports.

Police accused of exaggerating risks of HIV to introduce spit guards

Avon and Somerset police says the restraints will be used only when a person threatens to spit, has attempted to spit or has already spat. Photograph: Tim Ireland/PA A police force has been accused of fear mongering and stigmatising sufferers of hepatitis C and HIV by playing up the risks of transmission of blood-borne viruses as a reason to introduce spit guards. Avon and Somerset police announced their plan to issue spit guards to all operational officers from January next year. “Each d

Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

published: November, 01, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Hep B and C, Health, Revolving Door, Media, Guest Authors

"... we found that elevated coffee consumption had an independent protective effect on all-cause mortality risk.” From Infohep.org, Michael Carter reports.

Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection, French investigators report in the Journal of Hepatology. The protective effect of coffee consumption observed in the study was much larger than the 14% reduction in mortality observed in the general population. “In this large prospective nationwide cohort of patients co-infected with HIV-HCV followed-up in French hospital departments, we found t

Harm reduction saves lives -- please consider supporting PASAN.

published: September, 07, 2017 Written by // Guest Authors - Revolving Door Categories // Activism, Hep B and C, As Prevention , Fundraisers, Events, Treatment Guidelines -including when to start, General Health, Mental Health, Revolving Door, Treatment, Living with HIV, Guest Authors, Population Specific

PASAN has started a critical fundraising campaign.

Harm reduction saves lives -- please consider supporting PASAN.

PASAN is the only community-based organization in Canada providing HIV, AIDS and hepatitis C prevention, education and support services exclusively to prisoners, ex-prisoners and their families.  PASAN works with prisoners in provincial and federal corrections facilities throughout the province of Ontario, but faces tremendous constraints in doing this work. It’s become increasingly difficult for PASAN staff to be able to access prisons to conduct educational programming about harm redu

Hepatitis C: A silent killer and story that deserves more attention

published: July, 28, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, Hep B and C, CATIE, General Health, Health, CATIE - HIV and Hep C Info Resource, Media

From CATIE on the occasion of World Hepatitis Day (July 28), this report on the current state of the fight against Hepatitis C in Canada.

Hepatitis C: A silent killer and story that deserves more attention

Hepatitis C is a silent killer (people can have it for decades without any symptoms) and a story that is not commonly known in Canada. Yet this virus affects many people, highlights inequities in our health and social systems and is part of an important Canadian story. Canada has a history of being on the forefront of addressing hepatitis C, starting with Dr. Michael Houghton, an internationally recognized microbiologist at the University of Alberta, who was the first to co-discover hepatitis

What’s happening on the ground: first voice perspectives of the overdose crisis in Atlantic Canada

published: June, 22, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Conferences, Hep B and C, Current Affairs, General Health, Health, Revolving Door, Living with HIV, Guest Authors, Opinion Pieces

Guest author Michael Liddell: "... people who use drugs and their allies are using the mantra of 'nothing about us without us' to organize and demand action."

What’s happening on the ground: first voice perspectives of the overdose crisis in Atlantic Canada

At the opening of the 25th Harm Reduction International Conference in Montreal held in Montreal in May of this year, the Federal Minister of Health Jane Philpott announced that more people have died in the overdose epidemic in the past few years than during the height of the AIDS crisis in the late 80s and early 90s. This fact is made even more tragic considering that it need not happen. This grim reality was on the minds of many and was the catalyst for a workshop hosted by Direction 180

CTAC talks! Treating the sickest first: exploring Hepatitis C treatment in Canada

published: May, 17, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, Gay Men, As Prevention , Hep B and C, Treatment Guidelines -including when to start, Women, Health, Revolving Door, Treatment, Media, Guest Authors, Opinion Pieces

CTAC Talks is an innovative web series highlighting treatment access issues and solutions for Canadians living with HIV and Viral Hepatitis.

CTAC talks! Treating the sickest first: exploring Hepatitis C treatment in Canada

CTAC's expert guests, Dr. Lisa Barrett, Carrielynn Lund and Dr. Jordan Feld explore the current landscape of Hepatitis C treatment in Canada; a cure is available but there are significant treatment access barriers. For more information, visit the Canadian Treatment Access Council (CTAC), here.

CTAC Talks! PrEP: A Game Changer for HIV Prevention in Canada?

published: May, 11, 2017 Written by // Guest Authors - Revolving Door Categories // African, Caribbean and Black, Social Media, Hep B and C, Gay Men, Women, Revolving Door, Guest Authors, Opinion Pieces

CTAC Talks is an innovative web series highlighting treatment access issues and solutions for Canadians living with HIV and Viral Hepatitis.

CTAC Talks! PrEP: A Game Changer for HIV Prevention in Canada?

CTAC's expert guests, Joshua Edward, Dane Griffiths, Sipiwe Mapfumo and Fanta Ongoiba discuss the impact of Pre-Exposure Prophylaxis, or PrEP, which involves the use of antiretroviral medications by an HIV-negative person to prevent possible HIV transmission. For more information, visit the Canadian Treatment Access Council (CTAC), here.

2,100 miles on a bike: Barry Haarde is in the saddle again

published: April, 25, 2017 Written by // Bob Leahy - Publisher Categories // Hep B and C, Fitness and Exercise, Features and Interviews, Lifestyle, Living with HIV, Opinion Pieces, Bob Leahy - Publisher

Bob Leahy talks to long-time HIV and Hep C survivor Barry Haarde as he prepares to tackle his sixth marathon bike ride to raise awareness and money for hemophilia

2,100 miles on a bike: Barry Haarde is in the saddle again

Bob Leahy: Hi again Barry. Tell us about your route you will be travelling this time.  Barry Haarde: After completing five trans-continental tours in the U.S., including last year’s 5,000 mile trek from Seattle to Key West in 60 days, we decided to change things up a bit and ride the length of the Alaska Highway. The ride starts at “Mile 0” of the AlCan route in Dawson Creek, B.C. and tracks northwest in to Alaska, finishing near Fairbanks. Then, I’ll be riding an additional 650 mile

[12 3 4  >>  
Canadian Positive People Network/Reseau canadienne des personnes seropositives
Canadian Positive People Network/Reseau canadienne des personnes seropositives
CATIE
The Village Pharmacy